The UNAIDS 95-95-95 Goals and HIV Self-testing
The global market for HIV Self-test Kits is experiencing a period of unprecedented growth, driven by a convergence of public health initiatives, technological innovation, and a global focus on privacy and accessibility. These kits empower individuals to confidentially test for HIV in the comfort of their own homes, bypassing the logistical and social barriers of traditional clinical settings. The market's expansion is a direct response to the global health community's push to meet the ambitious UNAIDS 95-95-95 targets, aiming to ensure that 95% of people with HIV know their status.
The market has a strong financial outlook. Valued at an estimated USD 232.90 million in 2025, the sector is projected to reach approximately USD 442.40 million by 2030, exhibiting a robust Compound Annual Growth Rate (CAGR) of 7.55%. This growth is fueled by a global commitment to early diagnosis and prevention. The shift from a clinic-centric to a patient-centric model of care is a defining trend, with self-testing playing a pivotal role in reaching populations that are often underserved by conventional healthcare systems.
FAQs
What are the UNAIDS 95-95-95 targets? The targets aim for 95% of all people living with HIV to know their HIV status, 95% of all people with diagnosed HIV infection to receive sustained antiretroviral therapy, and 95% of all people receiving antiretroviral therapy to have viral suppression.
How do self-test kits help achieve the first target? Self-test kits are a crucial tool for the first "95," as they provide a private, confidential, and accessible way for individuals to get tested and know their status, particularly those who may not be reached by conventional clinic-based testing.